Trials / Completed
CompletedNCT01108900
A Study Of The Evaluation Of Patients Opulation With Erectile Dysfunction, Treated With Sildenafil
Non-Interventional, Prospective Study Of the Evaluation Of Patients Population With ED, Treated With Sildenafil
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
- Sex
- Male
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
In the present study, it is planned to observe a population of 100 ED patients treated previously with udenafil and for whom their physician decided to switch them to sildenafil because of poor udenafil tolerance and/or poor efficacy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | sildenafil | tables, 25,50,100 mg, on demand, 1 month |
Timeline
- Start date
- 2010-07-01
- Primary completion
- 2011-10-01
- Completion
- 2011-10-01
- First posted
- 2010-04-22
- Last updated
- 2021-02-01
Source: ClinicalTrials.gov record NCT01108900. Inclusion in this directory is not an endorsement.